Erol, M. 2023. IN SILICO EVALUATION OF SARS-COV-2 PAPAIN-LIKE PROTEASE INHIBITORY ACTIVITY OF SOME FDA-APPROVED DRUGS. Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.47, no.3 , 1-9.

Erol, M., (2023). IN SILICO EVALUATION OF SARS-COV-2 PAPAIN-LIKE PROTEASE INHIBITORY ACTIVITY OF SOME FDA-APPROVED DRUGS. Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.47, no.3, 1-9.

Erol, MERYEM. "IN SILICO EVALUATION OF SARS-COV-2 PAPAIN-LIKE PROTEASE INHIBITORY ACTIVITY OF SOME FDA-APPROVED DRUGS," Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.47, no.3, 1-9, 2023

Erol, MERYEM. "IN SILICO EVALUATION OF SARS-COV-2 PAPAIN-LIKE PROTEASE INHIBITORY ACTIVITY OF SOME FDA-APPROVED DRUGS." Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.47, no.3, pp.1-9, 2023

Erol, M. (2023) . "IN SILICO EVALUATION OF SARS-COV-2 PAPAIN-LIKE PROTEASE INHIBITORY ACTIVITY OF SOME FDA-APPROVED DRUGS." Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.47, no.3, pp.1-9.

@article{article, author={MERYEM EROL}, title={IN SILICO EVALUATION OF SARS-COV-2 PAPAIN-LIKE PROTEASE INHIBITORY ACTIVITY OF SOME FDA-APPROVED DRUGS}, journal={Ankara Üniversitesi Eczacılık Fakültesi Dergisi}, year=2023, pages={1-9} }